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The number of oldest old grew tremendously over the past few decades. However, recent studies have disclosed that the pace
of increase strongly varies among countries. The present study aims to specify the level of mortality selection among the
nonagenarians and centenarians living currently in five lowmortality countries, Denmark, France, Japan, Switzerland, and Sweden,
part of the 5-Country Oldest Old Project (5-COOP). All data come from the Human Mortality Database, except for the number
of centenarians living in Japan.We disclosed three levels of mortality selection, a milder level in Japan, a stronger level in Denmark
and Sweden and an intermediary level in France and Switzerland. These divergences offer an opportunity to study the existence of
a trade-off between the level of mortality selection and the functional health status of the oldest old survivors which will be seized
by the 5-COOP project.
1. Introduction
The number of very old people greatly increased during the
past few decades, for instance, the number of centenarians
(100+) increased from 154 people in Japan in 1963 when
the first centenarian list (Zenkoku koureisha meibo) was
released by the Ministry of Health and Welfare [1] to 40,399
people in 2009 [2]. In France, this number also increased
from a few hundred in 1950 to 14,944 by 2010 [3]. The
first study assessing the emergence of the centenarians at the
global level, in the mid 1990s, concluded that their number
doubled every 10 years since the 1960s in the low mortality
countries [4]. However, recent studies disclosed that the
pace of increase in the number of oldest old strongly varies
among the developed countries which are no longer in a
phase of convergence regarding their mortality conditions
[5]. Indeed during the 10-year period, from 1996 to 2006,
the number of centenarians was multiplied by 4 in Japan
while it was only multiplied by 2 in Europe [6]. Among the
27 European countries studied, this increase varied from a
factor higher than 2 in some countries such as Austria, Italy,
Germany, and Spain to a factor lower than 1.5 in Nordic or
Eastern European countries such as Norway, Iceland, Latvia,
Lithuania or Bulgaria.
During the same time various reports from Japan
suggested that the functional health status of the centenarian
people strongly decreased, especially their mobility with
a higher proportion of people bedridden or confined to
their house, as their number increased [5, 7, 8], while
Danish studies suggested a statu quo (cognitive scores), or
even an improvement for females (self reported ADLs), in
the functional health status of the centenarians living in
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Denmark [9, 10]. In absence of reports examining the change
over time in the functional health status of the centenarians
in other countries, these Japanese and Danish studies suggest
the possible existence of a trade-off between the proportion
of people reaching the age of 100 and the functional health
status of the survivors. Indeed the number of centenarians
was only multiplied by 1.6 in Denmark between 1996 and
2006 (1.3 for males and 1.7 for females) versus 4.2 in Japan
(3.0 for males and 4.5 for females) [6].
The trade-off between two characteristics, such as fer-
tility and longevity, is not an uncommon phenomenon in
biological science. Similar kinds of trade-offs seem to also
exist in the social sciences, such as that between the quantity
and the quality of goods. In population health science, this
has translated into the ongoing debate about the quantity
and quality of years lived and led to the development of
summary measures of population health, such as health
expectancies, in order to assess whether an increase in life
expectancy (quantity of life) is accompanied by an equivalent
increase in the quality of the years lived [11]. The existing
theories, “compression of morbidity” [12], “pandemic of
disability” [13, 14], and “dynamic equilibrium” [15], illus-
trate all possible combinations between the changes in the
quantity and quality of years lived. They do not provide a
theory on the relationship between the level of mortality
selection (how easy or difficult it is to survive to a given
age) and the functional health status of the survivors (i.e.,
the people reaching this given age). It is generally thought
that it is the frail who succumb first, leaving alive the more
robust. It has also been suggested that this selection may be
strong enough at the highest ages to virtually stop mortality
rates from rising, and even to result in a decline [16–18].
Kannisto has suggested that this selection process may impair
the health of some survivors leaving them frailer. Thus when
the selection process is stronger, causing extra deaths, the
health of many survivors is impaired [19]. Under these
conditions it seems difficult to predict the impact of the
level of mortality selection on the health status of survivors.
A stronger selection may only keep alive the most robust
individuals but the selective process itself may have impaired
them, while a milder selection may keep alive less robust
persons, but without having resulted in a deterioration of
their health.
The current divergence in the fall of mortality above
age 80 observed among the low mortality countries, and
therefore in the level of selection of the survivors at age 100,
offers an opportunity to study the existence of such a trade-
off between the level of mortality selection and the functional
health status of the oldest old survivors. This opportunity has
been seized by the 5-COOP project (5-Country Oldest Old
Project) which aims to accurately compare the health status
of centenarians living in Denmark, France, Japan, Sweden,
and Switzerland. Although the 5-COOP project will focus
on the cohorts of people born in 1911 (and later) who will
reach their 100th birthday from 2011 onwards, this paper
details the differences in mortality selection among the five
countries using the mortality history of the 1905 and 1910
cohorts.
The results are presented in three sections. After
Section 3.1 quickly reviews the centenarian figures,
Section 3.2 describes the mortality experiences of the
male and female 1905 birth cohorts, from age 50 in 1955 to
age 100 in 2005, as well as the mortality experiences of the
1910 birth cohorts, from age 50 in 1960 to age 95 in 2005.
Section 3.3 presents the results in terms of selection from the
80th to the 100th birthdates before the significance of the
observed differences in mortality selection is discussed.
This paper does not provide direct information on the
health status of the people currently reaching their 95th
or 100th year in the 5 countries of the study but merely
describes their mortality experience from ages 50 to ages 95
and 100, respectively.
2. Data
All data come from the Human Mortality Database—
HMD (http://www.mortality.org/), except for the number
of centenarians in Japan, and were downloaded in Spring
2009 for the number of centenarians and in Spring 2010
for the death rates. The numbers of centenarians used in
Section 3.1 are estimated by January first of each year (HMD,
period data, population size), except in Japan where a list
of living centenarians provided annually by the Ministry
of Health and Welfare has been used. The Japanese counts
are by September 30th. The death rates used in Sections 3.2
and 3.3 are cohort data coming without exception from the
HMD (HMD, cohort data, death rates). The centenarian
terminology is vague. Therefore, it is specified in the paper
when the number of centenarians (100) corresponds to
the people in the single age 100 and when the number of
centenarians (100+) corresponds to the people aged of 100
years and over.
3. Results
3.1. The Centenarian Figures in the Five Countries. Since
1946, the number of centenarians increased tremendously
in the five countries under study. However a quick look
at the graphs listed in Supplementary Material (Figure A1)
discloses significant differences in this increase. If it looks
exponential in France, it seems to be much more rapid
in Japan and conversely almost linear in Denmark. Table 1
summarizes this information over the last decade preceding
2006. Beyond the size effect, the Japanese population, being
about twofold the size of the French population, and the
latter being about ten times the size of the Swiss population,
it is clear that the pace of increase of the number of
centenarians is not similar in the five countries. It is much
more rapid in Japan and, comparatively, quite slow in
Denmark and Sweden, especially for males (Table 1).
The 10-year increase factor, 1996–2006 for both sexes,
varies from 4.2 in Japan to 1.6 in Denmark (2.0 in France,
1.9 in Switzerland and 1.7 in Sweden). The centenarian
population is predominantly a female population with a sex-
ratio close to six women for every man. Among the five
countries, it is at a maximum in France with a ratio of 7.1
in 2006 and minimum in Switzerland with a ratio of 5.3.
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Table 1: Number of centenarians (100+) in 2006 and 10-year increase by sex: Denmark, France, Japan, Sweden, and Switzerland.
Number of centenarians (100 and over) 10-Year increase
Country Males Females Sex-ratio Males Females
Japan 3906 23236 5.9 3.0 4.5
France 1532 10941 7.1 2.3 2.0
Switzerland 155 821 5.3 1.9 1.9
Sweden 194 1115 5.7 1.4 1.7
Denmark 99 581 5.9 1.3 1.7
These differences in the pace of increase in the number
of centenarians may be caused by two main factors, that is,
a differential in population growth and/or a differential in
mortality selection. The differential in population growth,
and especially the differential in birth cohort growth, clearly
contributed to the differences in the 10-year increase factor
between Japan and the four European countries. Indeed, in
the last quarter of the 19th century, the birth cohort size
significantly increased in Japan, moving from 869,126 new
born in 1875 to 1,420,534 new born in 1900. Although quite
important, such a growth cannot explain, by far, the observed
differences in the increase in the number of centenarians.
The following sections explore the second mechanism, that
is, the differential in mortality selection and its impact on
the number of centenarians, beginning at age 50.
3.2. The Mortality Experiences of the 1905 and 1910 Birth
Cohorts. The two cohorts, born in 1905 and 1910, have been
selected both for several practical and analytical purposes:
(i) availability of population and mortality data in the five
countries studied until ages 95 and 100, which are the ages
of interest in the 5-COOP project, (ii) proximity to the
cohorts which will be involved in 5-COOP, born in 1911 and
later, and (iii) correspondence with the study of the Danish
nonagenarian and centenarian cohorts [9, 10, 20–22].
The mortality experiences of the Japanese cohorts born
1905 and 1910 display a lower age mortality trajectory above
the age of 85 years compared to the four European countries
in the study. In detail (see Figures 1(a) and 1(b)), the
Japanese female cohort born in 1905 experienced a higher
level of mortality than the European cohorts of our study
from age 50, reached in 1955, to age 66, reached in 1971.
Then, the morality rates of the various countries overlap
until age 90, reached in 1995. From this age to the age of
100 years the Japanese cohort experienced the lowest level
of mortality. The Japanese cohort still experienced several
times the highest mortality level between ages 66 and 75,
and yet several times the lowest mortality level between age
75 and 90. The last time this Japanese cohort experienced
the highest mortality level was in 1980, at the age of 75
years, and the first time it experienced the lowest mortality
level was in 1985 at the age of 80 years. Compared to this
main difference, differences among European cohorts seem
to be quite small, though the French cohort seems to have
experienced an intermediary situation with a much larger
overlap with the other European cohorts.
The second Japanese female cohort born in 1910 experi-
enced a higher level of mortality than the European cohorts
of our study from age 50, reached in 1960, to age 59,
reached in 1969, with the exception of age 56. Then again
the mortality rates of the various cohorts overlap until age
85, reached in 1995. From this year, where the cohort has
reached its 85th birthday, this second Japanese cohort also
experienced the lowest level of mortality. The 1910 Japanese
cohort still experienced several times the highest mortality
level between ages 59 and 64, and yet several times the lowest
mortality level before age 85. The last time this Japanese
cohort experienced the highest mortality level was in 1974, at
age 64, and the first time it experienced the lowest mortality
level was in 1984, at age 74.
Except in 1960 at the age of 55 years, the Japanese
male cohort born in 1905 never experienced a higher level
of mortality than the European cohorts of our study. The
French male cohort experienced the highest mortality level
from age 50 to age 70, reached in 1975, age 55 excepted.
Conversely, from age 69 (in 1974) to age 100, the Japanese
cohort experienced the lowest level of mortality, if we make
exceptions for a few ages, that is, ages 75, 76, 82, 85–87,
89, 97–100. Although overlapping for a few years with other
trajectories, the Japanese mortality trajectory with age, above
the age of 70 years, is clearly lower than the European
trajectories. On the other hand, the Swedish male cohort
experienced the lowest mortality level from age 50 to age 68
(in 1973), with the exception of age 51, but experienced some
of the highest mortality levels at age 95 and above (ages 95,
96 and 98) from the year 2000 and on.
The Japanese male cohort born in 1910 also never
experienced a higher level of mortality than the European
countries of our study. The French male cohort experienced
the highest mortality level from age 50 to age 65, reached
in 1975. Before age 65, reached in 1975, the Swedish cohort
experienced the lowest level of mortality. At age 65 and above
the Japanese cohort experienced the lowest level of mortality,
if we exclude ages 82 and 84, ages at which the French
cohort experienced the lowest mortality levels. Thus, the
Japanese mortality trajectory with age is clearly lower than
the European trajectories above age 65. The Swedish male
cohort born in 1910 also experienced the lowest mortality
level before age 65 and some of the highest above age 90 (ages
91, 93 and 94).
Beyond the most spectacular differences (i.e., the female
Japanese cohorts experiencing the highest mortality levels
before the 1970s and the lowest after the mid 1990s, or
the male Swedish cohorts experiencing the lowest mortality
levels before the mid 1970s and some of highest levels
4 Current Gerontology and Geriatrics Research
Male birth cohort 1905
0
0.01
0.1
0
0.01
0.1
0
0.01
0.1
1
0
0.01
0.1
1
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
50 55 60 65 70 75 80 85 90 95 100
P
ro
ba
bi
lit
y
of
dy
in
g
(q
x)
50 55 60 65 70 75 80 85 90 95 100
50 55 60 65 70 75 80 85 90 95 100
50 55 60 65 70 75 80 85 90 95 100
50 55 60 65 70 75 80 85 90 95 100
50 55 60 65 70 75 80 85 90 95 100
0.45
0.5
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
P
ro
ba
bi
lit
y
of
dy
in
g
(q
x)
Male birth cohort 1905
50 55 60 65 70 75 80 85 90 95 100
0.45
0.5
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
P
ro
ba
bi
lit
y
of
dy
in
g
(q
x)
Female birth cohort 1905
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
50 55 60 65 70 75 80 85 90 95 100
P
ro
ba
bi
lit
y
of
dy
in
g
(q
x)
Female birth cohort 1905
Denmark
France
Sweden
Switzerland
Japan
Denmark
France
Sweden
Switzerland
Japan
Female birth cohort 1910
Male birth cohort 1910
Female birth cohort 1910
Male birth cohort 1910
(a) Arithmetic scale
(b) Logarithmic scale
Figure 1: Mortality trajectory with age, from age 50, in the cohorts born in 1905 and 1910: Denmark, France, Japan, Sweden, and Switzer-
land.
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since the year 2000), and some similarities between genders
within the same country, themortality experiences are clearly
country and gender specific. The Danish cohorts often, but
not always, experienced the highest morality levels since
the 1970s for females and since the mid 1970s for males.
The Swiss female cohorts regularly experienced the lowest
mortality in the 1970s and 1980s while the 1910 Swiss male
cohorts never experienced the highest or the lowest mortality
levels. Contrary to the male cohorts, the French female
cohorts never experienced the highest mortality levels. On
the contrary they experienced some of the lowest levels at
the beginning of the 1990s. These country-specific mortality
experiences led to different levels of selection for the cohort
members who reached their 95th birthday (birth cohort
1910) or 100th birthday (birth cohort 1905) during the
calendar year 2005 and which are detailed in the following
section.
The countries experiencing the lowest and the highest
mortality levels by single age, for each gender and each
cohort, through the age mortality trajectory above the age
of 50 years, are reported in Supplementary Material (Table
A1). The diagonal arrangement of the lowest and highest
mortality levels in this Table suggests a strong period effect,
the reasons for which will be debated in the discussion.
3.3. Selection from Age 80 to Age 100. The mortality selection
process which occurred in the five countries above the age of
80 years is represented on Figure 2.
For the female cohorts born in 1905 and for 100,000
survivors at age 80, it led to very similar numbers of
individuals surviving to age 100 in Denmark, Sweden,
and Switzerland (1,957, 2,014 and 2,022 people, resp.), a
noticeably higher number in France (2,928) and a strikingly
higher number in Japan (4,780). This offers three levels of
mortality selection: stronger (Denmark, Sweden, and Switz-
erland), milder (Japan) and intermediate (France).
For the male cohorts born in 1905, the mortality
selection from age 80 led to low numbers of individuals
surviving to 100 in Denmark and Sweden (532 and 570,
resp.), noticeably higher numbers in Switzerland and France
(776 and 856, resp.) and a strikingly higher number in
Japan (1,376). This offers again three levels of mortality
selection: stronger (Denmark and Sweden), milder (Japan)
and intermediate (France and Switzerland).
For the female cohorts born in 1910 (for 100,000 sur-
vivors at age 80), the mortality selection led to similar
numbers of individuals surviving to age 95 in Denmark
and Sweden (12,709 and 12,923, resp.), noticeably higher
numbers in Switzerland (14,241) and France (16,668) and a
strikingly higher number in Japan (21,974). This offers three
or four levels of mortality selection: stronger (Denmark and
Sweden), milder (Japan) and intermediate (France), with
Switzerland between France, on the one hand, and Denmark
and Sweden, on the other hand.
For the male cohorts born in 1910, the mortality selec-
tion from age 80 led also to similar numbers of individuals
surviving at age 95 in Denmark and Sweden (5,760 and
5,893, resp.), noticeably higher numbers in Switzerland
(6,995) and France (7,593) and a strikingly higher number
in Japan (9,622), offering three or four levels of mortality
selection: stronger (Denmark and Sweden), milder (Japan)
and intermediate (France) with Switzerland between France
and both Denmark and Sweden.
4. Discussion
During the decade, 1996–2006, the number of centenarians
in Japan increased two to three times faster compared with
Denmark and Sweden, and two times faster when compared
to Switzerland and France. The strong increase in the size of
the Japanese birth cohorts at the end of the 19th century
explained only a small part of the gaps. The main factor
which explains the observed differences in the pace of
increase in the numbers of oldest old in the five countries
studied is the differential in mortality selection at older ages.
Indeed, compared to Danish women, it has been 2.4 times
easier for Japanese women born in 1905, and still alive at age
80 in 1985 to become a centenarian in 2005 (2.6 times easier
for the male cohort) and 1.7 times easier for Japanese men
and women born in 1910 and still alive at age 80 in 1990 to
reach the age of 95 years in 2005 (see Table 2).
We studied the mortality experience of the various birth
cohorts beginning at age 50. This does not mean that
the mortality experience before age 50 does not matter in
determining the number of people surviving to age 100
[23, 24], but in this study we were more interested in the
mortality selection among adult people than in knowing how
many persons in a certain birth cohort became centenarians.
We are especially interested in the mortality selection among
the oldest old. This is the reason why the last section focused
on age 80 and above only. In a study of the demography of
centenarians in England andWales, it has been demonstrated
that improved survival from age 80 to age 100 explained at
least two times more the increase in the total numbers of
centenarians (100+) than improved survival from birth to
age 80 for the cohorts born between 1851 and 1896 [23].
The 1905 birth cohorts reached 50 years of age in 1955,
ten years after World War II. The 20th century was not a
tranquil century. The cohort born in 1905 and 1910 faced
wars in Asia and in Europe and severe economic crises in
their youth. The involvement of these cohorts in World War
I and II varied strongly according to country, year of birth,
and gender. Switzerland, for instance, escaped much of the
devastation of the wars while France and Japan suffered both
loss of manpower and destruction of property. Also, infant
mortality was high in both 1905 and 1910 and stood at
different levels in the five countries. However, recent studies
demonstrated the preponderance of period factors to explain
changes in mortality level, especially among the oldest old,
even if early life and middle life factors also contribute to
old age survival and mortality [25]. Nevertheless, ignoring
mortality before age 50 is a limitation of this study.
Although the mortality experiences starting at age 50
were specific for each cohort, our study disclosed strong
period effects punctuating these experiences. For instance,
among cohorts born in 1905 and 1910, Japanese females
experienced the highest level of mortality before 1970 and
the lowest after 1995. Similarly, the French male cohorts
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Figure 2: Survival curves from age 80, for the cohorts born in 1905 and 1910: Denmark, France, Japan, Sweden, and Switzerland.
Table 2: Chance to survive from 80 to 95 and 100 for cohorts born in 1905 and 1910: Denmark, France, Japan, Sweden, and Switzerland.
Denmark (= 1) France Sweden Switzerland Japan
Cohorts born in 1905: Chance to survive from 80 to 100
Females 1 1.5 1 1 2.4
Males 1 1.6 1.1 1.5 2.6
Cohorts born in 1910: Chance to survive from 80 to 95
Females 1 1.3 1 1.1 1.7
Males 1 1.3 1 1.2 1.7
experienced the highest mortality level before 1975 and
the Swedish male cohorts the lowest. These same Swedish
cohorts experienced some of the highest mortality levels
after 2000. In all these cases, the calendar year appears
more important than the year of birth. This helps us to
generalize the mortality experience of the oldest old of the
five countries.
In summary, our study disclosed three levels of mortality
selection among the centenarians currently living in the five
countries.
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(i) A milder level of selection in Japan. Indicated by the
fact that Japanese women who became centenarians
in 2005 had a 2.4 times higher chance to survive from
age 80 to 100 than their Danish counterparts (2.6
times higher chance for the male cohort). The better
mortality conditions observed in Japan are a recent
phenomenon. Indeed before 1970 Japanese women
experienced the highest level of mortality and crossed
over the mortality trajectories of the other countries
in the 1970s and 1980s.
(ii) A stronger level of selection in Denmark and Sweden.
Denmark and Sweden, almost experienced the oppo-
site mortality changes than Japan. Thus the worse
mortality conditions mainly observed today in Den-
mark, and secondarily in Sweden, are also recent
phenomena. In particular, before 1975, Swedish
cohorts experienced the lowest level of mortality.
(iii) An intermediary level of selection in France and
Switzerland. Indicated by the fact that the French
(males and females) and Swiss males who became
centenarians in 2005 had about a 1.5 times higher
chance to survive from age 80 to 100 compared to
their Danish counterparts—French men experienced
similar mortality changes to those experienced by
Japanese females. Indeed, before 1975, French males
experienced the highest mortality level while they are
second to Japan for the most recent years. On their
side, the Swiss cohorts underwent specific changes
over the same period of time. In particular the
Swiss female cohorts regularly experienced the lowest
mortality in the 1970s and 1980s.
These various epidemiologic histories have determined the
current levels of mortality selection met by the centenarians
living today in Denmark, France, Japan, Switzerland and
Sweden. Three levels have been identified, milder, stronger
and intermediary. However, due to the lack of studies or
the lack of comparative studies, it is impossible to assess
whether these different levels of selection have had an impact
on the health status of the survivors. On one side reports
have suggested a worsening in the functional health status
of centenarians living in Japan over time [7, 8]. On another
side reports have suggested a status quo (cognitive scores) and
even an improvement for women (self reported ADLs), in the
functional health status of centenarians living in Denmark
[9, 10]. Although there are no similar reports on the health
status of centenarians in Sweden, the Swedish Panel Study of
the Living Conditions of the Oldest Old (SWEOLD) suggests
some deterioration in the health status of the oldest old in
the recent years [26, 27]. In France as well as in Switzerland,
there is very little available information on the health status
of the oldest old. The Danish 1905 cohort study is clearly in
favor of the mainstream hypothesis that it is the frail who
succumb first, strongly limiting the increase of the prevalence
of geriatric conditions, such as ADL disability or dementia,
with age [22].
It is worth reminding that some conditions have an
effect on both disability and mortality, such as obesity and
cardiovascular diseases, some on disability only, such as
arthritis, macular degeneration or mild dementia, and some
mainly on mortality, such as cancer [28, 29]. In addition
to these various health outcomes specific for each disease,
the possible role of the balance between life-saving medical
interventions, rehabilitation of disabling conditions, and
prevention of both disabling and lethal conditions must
be mentioned. If a country mostly invests in life-saving
interventions, disregarding the disabling conditions, the
increased survival will be likely accompanied by an increase
in the prevalence of disability. Different health policies,
especially focusing on health behaviors such as alcohol and
tobacco consumption, can entail survivorships with different
functional health status. The characteristics of the daily care,
formal and informal, provided to the oldest old, should also
be at play. Can differences in survival between Europe and
Japan or within European countries be explained by such
factors?
It is in this context that the 5-Country Oldest Old
Project (5-COOP) aims to provide prevalence estimates for
a series of bio-markers, functional limitations, and geriatric
conditions, including dementia and cognitive disorders, at
ages 95 and 100, taking into account all available social
and physical environmental factors, that is, “what they get”,
in six different cultural settings: Denmark, France (South),
Japan (Tokyo and Okinawa), Switzerland and Sweden. These
countries have been selected for their low mortality level,
the quality of their population and mortality data [4,
6, 30–44], the possibility to draw representative samples
of nonagenarians and centenarians, and the existence of
research teams working on oldest-old issues [7–10, 20–22,
45–53].
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